Clifford Wilkinson, PA-C

NPI: 1326080433
Total Payments
$46.49
2023 Payments
$28.89
Companies
3
Transactions
3
Medicare Patients
82
Medicare Billing
$2,597

Payment Breakdown by Category

Food & Beverage$46.49 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $46.49 3 100.0%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $17.60 1 $0 (2021)
Astellas Pharma US Inc $16.05 1 $0 (2023)
Novo Nordisk Inc $12.84 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $28.89 2 Astellas Pharma US Inc ($16.05)
2021 $17.60 1 Merck Sharp & Dohme Corporation ($17.60)

All Payment Transactions

3 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/28/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $16.05 General
Category: Biological
04/21/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $12.84 General
Category: Diabetes
04/07/2021 Merck Sharp & Dohme Corporation GARDASIL 9 (Biological), ROTATEQ, PNEUMOVAX 23 Food and Beverage In-kind items and services $17.60 General
Category: VACCINE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 13 13 $910.00 $774.44
2022 3 46 47 $2,715 $1,219
2021 1 12 12 $816.00 $423.96
2020 1 11 11 $451.00 $179.52
Total Patients
82
Total Services
83
Medicare Billing
$2,597
Procedure Codes
6

All Medicare Procedures & Services

6 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza Office 2023 13 13 $910.00 $774.44 85.1%
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza Office 2022 16 16 $1,120 $486.67 43.5%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 12 12 $816.00 $421.49 51.7%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2022 18 19 $779.00 $310.43 39.8%
87426 Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 12 12 $816.00 $423.96 52.0%
87880 Strep test (streptococcus, group a) Office 2020 11 11 $451.00 $179.52 39.8%

About Clifford Wilkinson, PA-C

Clifford Wilkinson, PA-C is a Medical healthcare provider based in Sioux City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326080433.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Clifford Wilkinson, PA-C has received a total of $46.49 in payments from pharmaceutical and medical device companies, with $28.89 received in 2023. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($46.49).

As a Medicare-enrolled provider, Wilkinson has provided services to 82 Medicare beneficiaries, totaling 83 services with total Medicare billing of $2,597. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.

Practice Information

  • Specialty Medical
  • Other Specialties Physician Assistant
  • Location Sioux City, IA
  • Active Since 06/12/2006
  • Last Updated 06/14/2021
  • Taxonomy Code 363AM0700X
  • Entity Type Individual
  • NPI Number 1326080433

Products in Payments

  • GARDASIL 9 (Biological) $17.60
  • Veozah (Drug) $16.05
  • Rybelsus (Drug) $12.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Doctors in Sioux City